Rankings
▼
Calendar
JANX Q3 2023 Earnings — Janux Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
JANX
Janux Therapeutics, Inc.
$852M
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
+38.8% YoY
Gross Profit
$2M
80.1% margin
Operating Income
-$16M
-628.2% margin
Net Income
-$12M
-459.6% margin
EPS (Diluted)
$-0.25
QoQ Revenue Growth
+138.1%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$387M
Total Liabilities
$38M
Stockholders' Equity
$349M
Cash & Equivalents
$17M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$2M
+38.8%
Gross Profit
$2M
-$12M
+116.9%
Operating Income
-$16M
-$18M
+12.3%
Net Income
-$12M
-$17M
+30.7%
← FY 2023
All Quarters
Q4 2023 →